Skip to main content
VRNS
NASDAQ Technology

Varonis Systems Seeks Shareholder Approval for Significant Equity Plan Expansion

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
8
Price
$23.9
Mkt Cap
$2.807B
52W Low
$19.7
52W High
$63.9
Market data snapshot near publication time

summarizeSummary

Varonis Systems has filed its definitive proxy statement (DEF 14A) for its Annual Meeting on June 1, 2026, proposing several key items for shareholder vote. The most significant proposal is the approval of an increase of 6,402,279 shares for issuance under its 2023 Omnibus Equity Incentive Plan. This represents a potential dilution of approximately 5.57% relative to the current 114,814,150 shares outstanding. The company also notes that the total potential dilution, or 'overhang,' from all equity awards (outstanding and newly requested) would be approximately 13.5% of outstanding shares, which is a substantial amount. The company justifies this expansion as necessary to attract, motivate, and retain key talent, stating that a failure to approve could impede growth and necessitate higher cash-based incentives, adversely affecting earnings. This request for significant share authorization comes amidst a backdrop of widening net losses and a new securities class action lawsuit reported in the company's last 10-K, which could raise shareholder concerns about dilution. However, recent insider accumulation of over $1.1 million in open market purchases provides a conflicting signal, suggesting some internal confidence. The proxy also includes a non-binding 'say-on-pay' vote for executive compensation, where the CEO's 'compensation actually paid' for 2025 was notably negative, reflecting a decrease in the fair value of equity awards due to stock performance, despite high granted compensation. Other proposals include the routine election of four Class III directors and the ratification of the independent auditor.


check_boxKey Events

  • Equity Incentive Plan Expansion Proposed

    Shareholders will vote on adding 6,402,279 shares to the 2023 Omnibus Equity Incentive Plan. This represents a potential dilution of approximately 5.57% of current outstanding shares, with a total potential overhang of 13.5% from all equity awards. The company states this is vital for talent attraction and retention.

  • Executive Compensation Review

    The proxy includes a non-binding 'say-on-pay' vote for executive compensation. Notably, the CEO's 'compensation actually paid' for 2025 was negative, indicating a significant decline in the fair value of equity awards, aligning pay with stock performance.

  • Director Elections

    Four Class III director nominees, including CEO Yakov Faitelson and co-founder Ohad Korkus, are up for election to serve three-year terms. The board maintains a majority of independent directors and an independent Lead Director.

  • Auditor Ratification

    Shareholders are asked to ratify the appointment of Kost Forer Gabbay & Kasierer (a member of Ernst & Young Global Limited) as the independent registered public accounting firm for 2026.


auto_awesomeAnalysis

Varonis Systems has filed its definitive proxy statement (DEF 14A) for its Annual Meeting on June 1, 2026, proposing several key items for shareholder vote. The most significant proposal is the approval of an increase of 6,402,279 shares for issuance under its 2023 Omnibus Equity Incentive Plan. This represents a potential dilution of approximately 5.57% relative to the current 114,814,150 shares outstanding. The company also notes that the total potential dilution, or 'overhang,' from all equity awards (outstanding and newly requested) would be approximately 13.5% of outstanding shares, which is a substantial amount. The company justifies this expansion as necessary to attract, motivate, and retain key talent, stating that a failure to approve could impede growth and necessitate higher cash-based incentives, adversely affecting earnings. This request for significant share authorization comes amidst a backdrop of widening net losses and a new securities class action lawsuit reported in the company's last 10-K, which could raise shareholder concerns about dilution. However, recent insider accumulation of over $1.1 million in open market purchases provides a conflicting signal, suggesting some internal confidence. The proxy also includes a non-binding 'say-on-pay' vote for executive compensation, where the CEO's 'compensation actually paid' for 2025 was notably negative, reflecting a decrease in the fair value of equity awards due to stock performance, despite high granted compensation. Other proposals include the routine election of four Class III directors and the ratification of the independent auditor.

في وقت هذا الإيداع، كان VRNS يتداول عند ‏٢٣٫٩٠ US$ في NASDAQ ضمن قطاع Technology، مع قيمة سوقية تقارب ٢٫٨ مليار US$. تراوح نطاق التداول خلال 52 أسبوعًا بين ‏١٩٫٧٠ US$ و‏٦٣٫٩٠ US$. تم تقييم هذا الإيداع على أنه ذو معنويات سوقية محايدة وبدرجة أهمية ٨ من 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed VRNS - Latest Insights

VRNS
Apr 29, 2026, 4:27 PM EDT
Filing Type: 10-Q
Importance Score:
7
VRNS
Apr 28, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
VRNS
Apr 28, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
VRNS
Apr 17, 2026, 6:30 AM EDT
Filing Type: DEF 14A
Importance Score:
8
VRNS
Feb 04, 2026, 4:18 PM EST
Filing Type: 10-K
Importance Score:
8
VRNS
Feb 03, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7